Purchase Order 75F40126P00214

The Food and Drug Administration issued a $64,153.92 delivery order to Remel Inc. on July 2, 2026, for Sensititre-compatible supplies under a parent FDA single-award IDIQ. The parent contract is a $2.5 million indefinite delivery vehicle through March 20, 2026, supporting the FDA's National Antimicrobial Resistance Monitoring System and regulatory science initiatives across multiple delivery locations. Place of performance for this order is Laurel, MD. The order is priced on a firm fixed-price...

<p>The Food and Drug Administration issued a purchase order to the National Academy of Sciences on September 18, 2024, valued at $100,000.00, for FDA support to the NASEM Leadership Consortium. The order is firm fixed price with no set-aside designation. Performance takes place in Washington, DC 20418. Ultimate completion is scheduled for September 29, 2025.</p>

<p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (IDS Division) on August 30, 2018, for $150,035, with performance completion by September 29, 2019. The order covers an HPS Panel Design Starter Kit, firm fixed price, with place of performance in San Jose, California. The originating opportunity was posted as a special notice on August 15, 2018, with award following ten days after the August 25 deadline.</p>

<p>The Food and Drug Administration issued a purchase order to Parenteral Drug Association, Inc. for $74,916.00 on September 14, 2026, to support the Parenteral Drug Association/Food and Drug Administration Joint Regulatory Conference 2026 under Executive Order 14398. Place of performance is Washington, DC. The order carries a firm fixed price structure with an ultimate completion date of September 16, 2026. No small business set-aside applies.</p>

The Food and Drug Administration issued a purchase order to Creighton University for $154,452.00 on September 23, 2024. This is a no-cost modification extending the period of performance to March 13, 2026. Work is performed in Silver Spring, Maryland. The order funds further investigation of the association between β-lactamase enzyme expression and other proteins and antimicrobial resistance by studying additional gram-negative bacterial isolates. Pricing is firm fixed price with no small...

<p>The Food and Drug Administration issued a $87,791 delivery order to Information Management Services, Inc. on August 6, 2025, under the GSA Multiple Award Schedule for omics data statistical services.</p> <p>The order has a firm fixed price and ultimate completion date of August 10, 2030, covering a base period plus four option years. Place of performance is Silver Spring, MD. The ceiling value is $87,791.</p>

The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Co for $16,560.60 on August 23, 2021, to administrate de-obligation and de-obligation of unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these fiscal year funds. No set-aside was used. The order is firm fixed price. Work is performed at the vendor's facility in...

<p>The Food and Drug Administration issued a $380,540 delivery order to Molecular Epidemiology Inc., a woman-owned small business, on September 1, 2026, for microbial survey of FDA-regulated foods, agricultural water, and cosmetics. The order is issued under an FDA IDIQ contract for microbiological analysis services.</p> <p>Place of performance is Berwyn Heights, MD. The order is firm fixed price with an ultimate completion date of August 31, 2028. No set-aside was applied.</p>

<p>The Food and Drug Administration issued a $262,454.53 delivery order to Illumina, Inc. on September 1, 2026, for Illumina reagent chemistry kits, with an ultimate completion date of September 30, 2026.</p> <p>Place of performance is Berwyn Heights, MD. The order is priced firm fixed price with no set-aside.</p>

<p>The Food and Drug Administration issued a purchase order to The Food And Drug Law Institute, Inc. for $18,360 on July 21, 2026, to cover registration and attendance at the FDLI Enforcement, Litigation, and Compliance Conference. Performance occurs in Washington, DC. The order is firm fixed price with a completion date of December 11, 2026.</p>